An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

Louise A. Koopman; Maarten L. Janmaat; Kirstine Jacobsen; Mikkel Green Terp; Elke Gresnigt-van den Heuvel; Ulf Forssman; Andreas Lingnau; Paul W. Parren; Henrik Ditzel; Esther C. Breij

doi:10.1158/1538-7445.AM2018-832

An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

Louise A. Koopman
, Maarten L. Janmaat
, Kirstine Jacobsen
, Mikkel Green Terp
, Elke Gresnigt-van den Heuvel
, Ulf Forssman
, Andreas Lingnau
, Paul W. Parren
, Henrik Ditzel
, Esther C. Breij

Institut for Biokemi og Molekylær Biologi

Genmab BV
Leiden University Medical Center

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Artikelnummer	832
Tidsskrift	Cancer Research
Vol/bind	78
Udgave nummer	Suppl. 13
ISSN	0008-5472
DOI	https://doi.org/10.1158/1538-7445.AM2018-832
Status	Udgivet - jul. 2018
Begivenhed	AACR annual meeting 2018 - Chicago, USA Varighed: 14. apr. 2018 → 18. apr. 2018

Konference

Konference	AACR annual meeting 2018
Land/Område	USA
By	Chicago
Periode	14/04/2018 → 18/04/2018

Bibliografisk note

Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, APR 14-18, 2018

Dokumenter og links

10.1158/1538-7445.AM2018-832

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Koopman, L. A., Janmaat, M. L., Jacobsen, K., Terp, M. G., Gresnigt-van den Heuvel, E., Forssman, U., Lingnau, A., Parren, P. W., Ditzel, H., & Breij, E. C. (2018). An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC. Cancer Research, 78(Suppl. 13), Artikel 832. https://doi.org/10.1158/1538-7445.AM2018-832

@article{86ae74374959472c8579883be9b0a193,

title = "An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC",

author = "Koopman, \{Louise A.\} and Janmaat, \{Maarten L.\} and Kirstine Jacobsen and Terp, \{Mikkel Green\} and \{Gresnigt-van den Heuvel\}, Elke and Ulf Forssman and Andreas Lingnau and Parren, \{Paul W.\} and Henrik Ditzel and Breij, \{Esther C.\}",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, APR 14-18, 2018; AACR annual meeting 2018 ; Conference date: 14-04-2018 Through 18-04-2018",

year = "2018",

month = jul,

doi = "10.1158/1538-7445.AM2018-832",

language = "English",

volume = "78",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "Suppl. 13",

}

Koopman, LA, Janmaat, ML, Jacobsen, K, Terp, MG, Gresnigt-van den Heuvel, E, Forssman, U, Lingnau, A, Parren, PW, Ditzel, H & Breij, EC 2018, 'An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC', Cancer Research, bind 78, nr. Suppl. 13, 832. https://doi.org/10.1158/1538-7445.AM2018-832

TY - ABST

T1 - An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC

AU - Koopman, Louise A.

AU - Janmaat, Maarten L.

AU - Jacobsen, Kirstine

AU - Terp, Mikkel Green

AU - Gresnigt-van den Heuvel, Elke

AU - Forssman, Ulf

AU - Lingnau, Andreas

AU - Parren, Paul W.

AU - Ditzel, Henrik

AU - Breij, Esther C.

N1 - Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, APR 14-18, 2018

PY - 2018/7

Y1 - 2018/7

U2 - 10.1158/1538-7445.AM2018-832

DO - 10.1158/1538-7445.AM2018-832

M3 - Conference abstract in journal

SN - 0008-5472

VL - 78

JO - Cancer Research

JF - Cancer Research

IS - Suppl. 13

M1 - 832

T2 - AACR annual meeting 2018

Y2 - 14 April 2018 through 18 April 2018

ER -